Suppr超能文献

肾移植:未来的挑战

Kidney transplantation: future challenges.

作者信息

Veroux M, Corona D, Veroux P

机构信息

Department of Surgery, Transplantation and Advanced Technologies, Vascular Surgery and Organ Transplant Unit, University Hospital of Catania, Catania, Italy.

出版信息

Minerva Chir. 2009 Feb;64(1):75-100.

Abstract

Kidney transplantation is the best replacement therapy for the patients with end-stage renal disease, by offering an increased longevity and quality of life. However, the demand for kidney exceeds the available supply, so that the number of people on waiting list is steadily increasing. Many transplant centers have tried to supply to this chronic shortage of organs, by utilizing kidney from older donors or from donors with a previous hepatitis, and this strategy resulted in a safe way to increase the donor pool. Living transplantation has progressively increased in last years so that the number of living donors exceeds in the USA the deceased donors. Although one-year graft survival is excellent, long-term outcomes has not improved in last years. Death from cardiovascular disease, infection and malignancy are common complications of immunosuppression and are the leading causes of mortality in kidney transplant recipients. Viral infections and donor-transmitted infections will be probably the emerging challenge in the next years. Physicians must be aware in developing newer immunosuppressive regimens, with lower side effects, which may improve the long-term outcome of kidney transplantation. Reduction of death with functioning graft and chronic allograft nephropathy will be the greatest challenge of all physicians who care for kidney transplant recipients.

摘要

肾移植是终末期肾病患者最佳的替代治疗方法,可延长患者寿命并提高生活质量。然而,肾脏的需求超过了可获得的供应,因此等待名单上的人数在稳步增加。许多移植中心试图通过使用老年供体或曾患肝炎的供体的肾脏来解决长期存在的器官短缺问题,这一策略为增加供体库提供了一种安全的方式。近年来,活体移植逐渐增加,在美国,活体供体的数量超过了 deceased donors(这里原文有误,推测可能是“ deceased donors”,即 deceased 应为“已故的”,整体意思是已故供体)。尽管移植肾一年生存率很高,但近年来长期疗效并未改善。心血管疾病、感染和恶性肿瘤导致的死亡是免疫抑制的常见并发症,也是肾移植受者死亡的主要原因。病毒感染和供体传播感染可能是未来几年新出现的挑战。医生在制定副作用更小的新型免疫抑制方案时必须保持警惕,这可能会改善肾移植的长期疗效。减少有功能移植物的死亡和慢性移植肾肾病将是所有照顾肾移植受者的医生面临的最大挑战。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验